Vamotinib
Vamotinib (PF-114) is an orally active and specific tyrosine kinase inhibitor with antiproliferative and antitumour activity.Vamotinib inhibits the phosphorylation of BCR/ABL and BCR/ABL-T315I, which promotes apoptosis. Vamotinib is used to study drug-resistant Philadelphia chromosome-positive (Ph+) leukaemia and Alzheimer's disease.
Product Specifications
CAS Number
1416241-23-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
532.56
Molecular Formula
C29H27F3N6O
Notes
Research use only, not for human use.
Receptor
Bcr-Abl | Apoptosis | Tyrosine Kinases
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RELMB21-S 100 µL
Anti-Mouse Resistin-Like protein beta (RELM-beta/FIZZ2) antiserum #1
Sign In for Pricing
View Details 
MBS962304-01 0.02 mg (E-Coli)
Recombinant Mouse 55 kDa erythrocyte membrane protein (Mpp1)
Sign In for Pricing
View Details MBS962304-02 0.02 mg (Yeast)
Recombinant Mouse 55 kDa erythrocyte membrane protein (Mpp1)
Sign In for Pricing
View Details